Innovent Biologics Eulerpool News

Innovent Biologics Eulerpool News

Innovent Biologics Aktie News

Innovent Biologics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Innovent Biologics News stellen wir hier zusammen.

• 11. September ·

  Yahoo
  Innovent Delivers Oral Presentation on Phase 1 Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer at the 2024 WCLC
• 10. September ·

  Yahoo
  Innovent Delivers Oral Presentation of Updated Results from a Pivotal Phase 2 Study of Dupert® (Fulzerasib) in Patients with Advanced Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation
• 9. September ·

  Yahoo
  High Growth Tech Stocks to Watch in Hong Kong September 2024
• 9. September ·

  Yahoo
  SEHK Value Picks That Could Be Undervalued In September 2024
• 9. September ·

  Yahoo
  High Growth Tech Stocks In Hong Kong Featuring 3 Prominent Picks
• 4. September ·

  Yahoo
  FDA grants fast track status to Innovent’s IBI363 for melanoma
• 4. September ·

  Yahoo
  Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma
• 2. September ·

  Yahoo
  Innovent Annouces Multiple Clinical Study Results of Mazdutide to be Presented at the EASD 2024
• 29. August ·

  Yahoo
  Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024
• 28. August ·

  Yahoo
  Innovent Announces 2024 Interim Results and Business Updates